Monte Rosa Therapeutics, Inc.
NASDAQ:GLUE
9.53 (USD) • At close November 7, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||||||
| Current Assets: | ||||||||||||||||
| Cash & Cash Equivalents
| 108.847 | 99.752 | 128.101 | 59.055 | 47.027 | 51.847 | 54.912 | 112.394 | 103.664 | 138.305 | 346.071 | 367.034 | 357.06 | 168.436 | 41.699 | -5.995 |
| Short Term Investments
| 153.358 | 93.14 | 104.312 | 119.422 | 156.039 | 179.887 | 207.914 | 159.755 | 190.481 | 178.858 | 0 | 0 | 0 | 0 | 0 | 11.99 |
| Cash and Short Term Investments
| 262.205 | 192.892 | 232.413 | 178.477 | 203.066 | 231.734 | 262.826 | 272.149 | 294.145 | 317.163 | 346.071 | 367.034 | 357.06 | 168.436 | 41.699 | 5.995 |
| Net Receivables
| 9.842 | 0.601 | 0.505 | 0.294 | 1.154 | 2.17 | 7.656 | 17.557 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0.96 | 0.96 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 5.849 | 5.543 | 3.294 | 4.14 | 3.884 | 5.692 | 4.444 | 5.529 | 2.9 | 3.203 | 2.595 | 3.485 | 1.229 | 3.271 | 1.892 | 0 |
| Total Current Assets
| 277.896 | 199.036 | 236.212 | 182.911 | 208.104 | 240.556 | 275.886 | 295.235 | 297.045 | 320.366 | 348.666 | 370.519 | 358.289 | 171.707 | 43.591 | 5.995 |
| Non-Current Assets: | ||||||||||||||||
| Property, Plant & Equipment, Net
| 61.143 | 62.458 | 62.611 | 64.4 | 65.694 | 63.8 | 61.907 | 57.918 | 62.307 | 20.306 | 12.325 | 11.801 | 8.923 | 7.732 | 4.623 | 0 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 4.866 | 4.863 | 4.58 | 4.522 | 4.527 | 4.321 | 4.318 | 4.302 | 5.32 | 5.333 | 5.338 | 1.729 | 1.729 | 1.164 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.209 | 0.389 | 0.352 | 0.27 | 0.291 | 0.351 | 0.278 | 0.148 | 0.384 | 0 | 0 | 0 | 0 | 0 | 1.164 | -5.995 |
| Total Non-Current Assets
| 66.218 | 67.71 | 67.543 | 69.192 | 70.512 | 68.472 | 66.503 | 62.368 | 68.011 | 25.639 | 17.663 | 13.53 | 10.652 | 8.896 | 5.787 | -5.995 |
| Total Assets
| 344.114 | 266.746 | 303.755 | 252.103 | 278.616 | 309.028 | 342.389 | 357.603 | 365.056 | 346.005 | 366.329 | 384.049 | 368.941 | 180.603 | 49.378 | 0 |
| Liabilities & Equity: | ||||||||||||||||
| Current Liabilities: | ||||||||||||||||
| Account Payables
| 6.473 | 6.828 | 11.152 | 5.5 | 5.308 | 7.382 | 7.862 | 9.753 | 4.294 | 4.511 | 6.558 | 3.53 | 7.463 | 7.326 | 7.066 | 0 |
| Short Term Debt
| 3.471 | 3.345 | 3.162 | 2.881 | 2.667 | 2.89 | 3.127 | 3.065 | 2.662 | 1.524 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 19.645 | 20.407 | 17.678 | 11.32 | 8.658 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities
| 12.759 | 10.713 | 14.6 | 2.908 | 2.456 | 10.243 | 14.58 | 8.972 | 7.817 | 6.455 | 10.08 | 9.213 | 3.328 | 1.765 | 22.209 | 0 |
| Total Current Liabilities
| 42.348 | 41.293 | 46.592 | 22.609 | 19.089 | 20.515 | 25.569 | 21.79 | 14.773 | 12.49 | 16.638 | 12.743 | 10.791 | 9.091 | 29.275 | 0 |
| Non-Current Liabilities: | ||||||||||||||||
| Long Term Debt
| 40.885 | 41.837 | 42.877 | 43.517 | 44.368 | 43.275 | 43.874 | 42.593 | 46.095 | 5.457 | 0 | 0 | 0 | 231.172 | 0 | 0 |
| Deferred Revenue Non-Current
| 33.596 | 28.529 | 32.323 | 1.453 | 1.505 | 1.512 | 0 | 2.128 | 2.138 | 2.183 | 0 | 2.001 | 1.472 | 0.956 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | -1.453 | -1.505 | -1.512 | 0 | -2.128 | -2.138 | -2.183 | 0 | 0 | 0 | -232.128 | 0 | 0 |
| Other Non-Current Liabilities
| 2.614 | 2.568 | 2.713 | 1.453 | 1.505 | 1.512 | 1.533 | 2.128 | 2.138 | 0 | 2.176 | 0 | 0 | 0 | 68.831 | 0 |
| Total Non-Current Liabilities
| 77.095 | 72.934 | 77.913 | 44.97 | 45.873 | 44.787 | 45.407 | 44.721 | 48.233 | 7.64 | 2.176 | 2.001 | 1.472 | 232.128 | 68.831 | 0 |
| Total Liabilities
| 119.443 | 114.227 | 124.505 | 67.579 | 64.962 | 65.302 | 70.976 | 66.511 | 63.006 | 20.13 | 18.814 | 14.744 | 12.263 | 241.219 | 98.106 | 0 |
| Equity: | ||||||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 384.049 | 368.941 | 231.172 | 67.764 | 18.95 |
| Common Stock
| 0.006 | 0.005 | 0.005 | 0.005 | 0.005 | 0.005 | 0.005 | 0.005 | 0.005 | 0.005 | 0.005 | 0.005 | 0.004 | 0.001 | 0.001 | 0 |
| Retained Earnings
| -428.166 | -397.856 | -365.888 | -332.636 | -297.752 | -262.574 | -230.536 | -199.754 | -172.436 | -145.967 | -122.035 | -98.595 | -78.758 | -60.353 | -48.077 | 0 |
| Accumulated Other Comprehensive Income/Loss
| -2.67 | -2.693 | -2.724 | -1.455 | -1.64 | -1.393 | -1.752 | -2.602 | -2.458 | -2.133 | -2.021 | -1.95 | -1.415 | -0.92 | -1.056 | -12.148 |
| Other Total Stockholders Equity
| 655.501 | 553.063 | 547.857 | 518.61 | 513.041 | 507.688 | 503.696 | 493.443 | 476.939 | 473.97 | 471.566 | 85.796 | 67.906 | -230.516 | -67.36 | 0 |
| Total Shareholders Equity
| 224.671 | 152.519 | 179.25 | 184.524 | 213.654 | 243.726 | 271.413 | 291.092 | 302.05 | 325.875 | 347.515 | 369.305 | 356.678 | -60.616 | -48.728 | 6.802 |
| Total Equity
| 224.671 | 152.519 | 179.25 | 184.524 | 213.654 | 243.726 | 271.413 | 291.092 | 302.05 | 325.875 | 347.515 | 369.305 | 356.678 | -60.616 | -48.728 | 6.802 |
| Total Liabilities & Shareholders Equity
| 344.114 | 266.746 | 303.755 | 252.103 | 278.616 | 309.028 | 342.389 | 357.603 | 365.056 | 346.005 | 366.329 | 384.049 | 368.941 | 180.603 | 49.378 | 6.802 |